![]() |
市场调查报告书
商品编码
1453940
2030 年三丁酸甘油酯市场预测:按类型、纯度等级、应用和地区进行的全球分析Tributyrin Market Forecasts to 2030 - Global Analysis By Type (Powder, Liquid and Other Types), Purity Level (Purity 45% and Below, Purity 45% - 99% and Purity 99% and Above), Application (Swine, Poultry and Other Applications) and by Geography |
根据Stratistics MRC的数据,2023年全球三丁酸甘油酯市场规模为1.3748亿美元,预计到2030年将达到2.9455亿美元,预测期内复合年增长率为11.5%。
三丁酸甘油酯是一种三酸甘油酯,更准确地说是由短链脂肪酸丁酸製成的三酯。它由三个酯化至甘油主链的丁酸分子组成。三丁酸甘油酯天然存在于一些脂肪和油中,其特殊性质使其广泛应用于食品和製药行业。丁酸盐作为前驱药物,具有多种健康益处,包括发炎和抗癌作用。
根据美国心臟协会的说法,保持健康的生活方式(包括定期运动和均衡饮食)对于心血管健康至关重要。
增加消化器官系统健康知识
消费者越来越意识到短链脂肪酸(特别是丁酸)在支持肠道健康方面发挥的重要作用,这推动了三丁酸甘油酯市场的显着成长。随着人们越来越意识到饮食如何影响整体健康,对含有三丁酸甘油酯的产品的需求正在增加。此外,食品和营养补充食品是这一趋势最明显的例子,因为消费者寻求促进消化器官系统健康的机能性食品。
缺乏客户知识
客户缺乏对三丁酸甘油酯潜在健康益处的了解是一个主要的市场限制。由于许多人对三丁酸甘油酯不熟悉,可能会阻碍这种化合物在各种消费品中的广泛采用。此外,教育和宣传宣传活动对于克服这一障碍并促进消费者了解三丁酸甘油酯的好处至关重要。
人们对机能性食品的认识不断增强
由于消费者对机能性食品的兴趣日益浓厚,三丁酸甘油酯市场潜力巨大。越来越多的人开始意识到机能性食品,它们提供的健康益处超越了基本饮食。此外,随着消费者倾向于支持全身健康的食品,丁酸可以添加到各种机能性食品中,并可能对肠道健康产生积极影响。
对长期影响的研究不足
对三丁酸甘油酯长期影响的研究不足可能会威胁到市场扩张。儘管初步研究表明可能对健康有益,但缺乏彻底、长期的研究可能会对三丁酸甘油酯的长期安全性和有效性产生怀疑。此外,为了获得消费者的信任,必须进行彻底的研究和临床试验来弥补这一差距。
三丁酸甘油酯市场受到了 COVID-19 大流行的各种影响。由于全球供应链中断、製造业务有限和经济不确定性,市场参与企业面临挑战。由于大流行,消费者对健康和保健意识的增强刺激了对某些营养补充的需求,但整体市场成长受到消费行为变化和景气衰退的限制。
预计液体部分在预测期内将是最大的
在曲替林市场中,液体部分占据最大份额。液体三丁酸甘油酯具有广泛的应用,使其在製药行业中特别受欢迎,因为可以轻鬆测量和施用精确的剂量。液体丁酸也广泛用于动物营养,因为它很容易掺入饲料中。其流动性有利于有效混合,使其成为产品配方必须均匀的行业的首选。
预计 99% 以上的纯度部分在预测期内将呈现最高的复合年增长率。
在印花布市场中,纯度为 99% 或更高的细分市场的复合年增长率最高。由于製药业需要精确和纯的化合物用于治疗配方,因此对高纯度丁酸的需求不断增加。随着製药业专注于使用三丁酸甘油酯作为前驱药物的药物的研究和开发,特别是用于丁酸的输送,高纯度细分市场正在经历强劲增长。此外,在特色食品、高端化妆品等注重配方精度的行业中,首选纯度99%以上的三西林。
预计欧洲地区将占据全球三丁酸甘油酯产业的最大市场占有率。欧洲市场的强劲得益于蓬勃发展的製药业,该行业对三尖瓣的医疗用途进行了广泛的研究。该地区致力于透过机能性食品和营养补充促进消化器官系统健康,食品推动了对含曲替林产品的需求。此外,由于欧盟 (EU) 完善的动物营养产业,三丁酸甘油酯被接受作为牲畜饲料添加剂。欧洲消费者健康和福祉意识的提高,加上严格的法律规范,正在推动三替林市场的扩张。
在全球毛蛋白市场中,亚太地区的复合年增长率最高。该地区的爆炸性增长是由製药和医疗保健行业的增长以及公众对 tricityline 健康益处的了解不断增加所推动的。对预防性医疗保健的日益重视、饮食习惯的改变和可支配收入的增加都促进了对食品三丁酸甘油酯的机能性食品和营养补充的需求。此外,亚太地区动物营养产业的成长以及对牲畜健康的关注是在动物饲料配方中添加丁酸的主要推动力。
According to Stratistics MRC, the Global Tributyrin Market is accounted for $137.48 million in 2023 and is expected to reach $294.55 million by 2030 growing at a CAGR of 11.5% during the forecast period. Tributyrin is a triglyceride, or more precisely, a triester made from the short-chain fatty acid butyric acid. It consists of three butyric acid molecules esterified to a glycerol backbone. Tributyrin, which is naturally present in some fats and oils, is widely used in the food and pharmaceutical industries due to its special qualities. Acting as a prodrug, butyric acid has been linked to several health advantages, such as its anti-inflammatory and anti-cancer characteristics.
According to the American Heart Association, maintaining a healthy lifestyle, including regular physical activity and a balanced diet, is crucial for cardiovascular well-being.
Growing knowledge about digestive health
Due to growing consumer awareness of the critical role that short-chain fatty acids, especially butyric acid, play in supporting gut health, the tributyrin market is expanding significantly. Product demand for tributyrin-containing products is increasing as people become more aware of how their diet affects their overall health. Moreover, the food and nutritional supplement industries are showing this trend most clearly as consumers look for functional foods that promote digestive health.
Insufficient knowledge of customers
Customer's lack of knowledge about tributyrin's potential health benefits is a major market constraint. The compound's widespread adoption in various consumer products may be hampered by the lack of familiarity with it among a large number of people. Additionally, to overcome this obstacle and promote consumer comprehension of tributyrin's advantages, education and awareness campaigns are essential.
Growing awareness of functional foods
The market for tributyrin has a lot of potential because of the growing consumer interest in functional foods. More people are becoming aware of functional foods, which provide health advantages over a basic diet. Furthermore, gaining from the trend of consumers looking for foods that support their overall well-being, butyrin can be added to a range of functional food products and may have a positive effect on gut health.
Insufficient studies on prolonged impacts
The expansion of the market may be threatened by the paucity of studies on tributyrin's long-term effects. Although preliminary research indicates possible health advantages, a dearth of thorough, extended investigations could give rise to doubts regarding the long-term safety and effectiveness of tributyrin. Moreover, gaining the trust of consumers requires conducting thorough research and clinical trials to close this gap.
The tributyrin market has experienced a variety of effects from the COVID-19 pandemic. Market participants have faced difficulties as a result of disruptions in the global supply chain, limitations on manufacturing operations, and economic uncertainties. The demand for specific nutritional supplements has been fueled by the pandemic's increased consumer awareness of health and wellness, but overall market growth has been restrained by changes in consumer behavior and economic downturns.
The Liquid segment is expected to be the largest during the forecast period
In the market for tricytyrin, the liquid segment has the largest share. Tributyrin in liquid form is preferred due to its adaptability to a wide range of applications, especially in the pharmaceutical industry, where accurate dosages are simple to measure and administer. Animal nutrition also makes extensive use of liquid butyrin, which is easy to incorporate into feed formulations. Because of its fluidity, which facilitates effective mixing, it is a recommended option for industries where product formulations must be uniform.
The Purity 99% and Above segment is expected to have the highest CAGR during the forecast period
In the trichome market, the segment of purity of 99% and above has the highest CAGR. Because precise and pure compounds are necessary for therapeutic formulations in the pharmaceutical industry, there is a growing demand for high-purity butyrin. The high-purity segment has experienced robust growth due to the pharmaceutical industry's emphasis on research and development of drugs that use tributyrin as a prodrug, especially for the delivery of butyric acid. Moreover, businesses that prioritize formulation accuracy, like specialty food items and high-end cosmetics, favor tricyrin that has a purity level of 99% or higher.
The region of Europe is projected to possess the largest market share in the worldwide tributyrin industry. The strength of the European market stems from a thriving pharmaceutical industry that conducts extensive research on the medicinal uses of tricuspid valves. The demand for products containing tricyrin has increased due to the region's growing emphasis on promoting digestive health through functional foods and nutraceuticals. Furthermore, tributyrin's acceptance as a feed additive for livestock can be attributed to the European Union's well-established animal nutrition industry. European consumers growing consciousness of health and well-being, combined with strict regulatory frameworks, has made the market for tricytyrin growth conducive to expansion.
In the global trichomerin market, the Asia-Pacific region exhibits the highest CAGR. The growing pharmaceutical and healthcare sectors, along with growing public knowledge of the health advantages of tricytyrin, are driving the region's explosive growth. Growing emphasis on preventive healthcare, shifting dietary habits, and rising disposable income all contribute to the demand for functional foods and dietary supplements that contain tributyrin. Moreover, the growth of the animal nutrition industry in Asia-Pacific and the focus on livestock health are the main factors behind the addition of butyrin to animal feed formulations.
Key players in the market
Some of the key players in Tributyrin market include Perstorp Holding AB, Hangzhou FandaChem Co., Ltd., Shanghai Smart Chemicals Co., Ltd., Jefo Nutrition Inc., Kemcolour International, Vetagro S.p.A, Penta Manufacturer, TCI Development Co., Ltd, Prinova Group LLC and Merck KGaA.
In February 2024, Sweden-based specialty chemicals company Perstorp has built and commissioned a new ISCC Plus-certified plant in western India to meet the growing market demand for Penta chemicals. Located in Sayakha, Bharuch, in the state of Gujarat, the facility was officially inaugurated on Feb. 20. This is the largest investment in Asia so far, in Perstorp's history. It will further strengthen Perstorp's position as a sustainable and reliable partner in the region of Asia, commented Gorm Jensen, Perstorp's Executive Vice President Commercial & Innovation.
In December 2023, Transcargo International, TCI, a veteran terminal operator in Egypt, announces the signing of an agreement with Sinai White Portland Cement, SWCC, for the development of Egypt's first bulk cement silos in Arish Port, marking a significant milestone in the cement industry in Egypt and its export capabilities.
In December 2023, Merck has signed an agreement in Germany for the commercialisation of products that include or contain Abbisko Therapeutics' pimicotinib (ABSK021) for all indications. Merck will receive an exclusive licence to market the products in licensed territories comprising the Chinese mainland, Hong Kong, Macau and Taiwan. The exclusive rights for the development of pimicotinib in the licensed territories will be retained by Abbisko.